Sagimet Biosciences (SGMT) Shares Issued (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Shares Issued of $4.0 million for Q1 2026, up 45.83% year-over-year from $2.7 million in Q1 2025, and down 30.14% quarter-over-quarter from $5.7 million in Q4 2025.
Sagimet Biosciences (SGMT) Shares Issued (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Shares Issued history runs 5 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Shares Issued rose 45.83% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 45.83% YoY), while the FY2025 annual figure was $5.7 million, up 28.23% from the prior year.
- Shares Issued for Q1 2026 stood at $4.0 million, down from $5.7 million in the prior quarter.
- The five-year high for Shares Issued was $5.7 million in Q2 2025, with the low at $1.7 million in Q2 2023.
- The 5-year median for Shares Issued is $3.4 million (2025), against an average of $3.5 million.
- The sharpest annual moves came in 2023 and 2024: Shares Issued gained 17.65% in 2023, then jumped 167.07% in 2024.
- Sagimet Biosciences' Shares Issued stood at $3.2 million in 2022, then gained by 17.65% to $3.8 million in 2023, then rose by 18.89% to $4.5 million in 2024, then advanced by 28.23% to $5.7 million in 2025, then slumped by 30.14% to $4.0 million in 2026.
- Business Quant data shows SGMT's Shares Issued at $4.0 million in Q1 2026, $5.7 million in Q4 2025, and $3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - | 7.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.57 Mn |
| Jun 30, 2026 | 7.57 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 5.72 Mn |
| Dec 31, 2025 | 5.72 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 5.74 Mn |
| Jun 30, 2025 | 5.74 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | 4.46 Mn |
| Dec 31, 2024 | 4.46 Mn |
| Sep 30, 2024 | 2.31 Mn |
| Sep 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 4.46 Mn |
| Jun 30, 2024 | 4.46 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Mar 31, 2024 | 2.27 Mn |